Multivariable linear regression for school/college attendance
| Independent variable | β-coefficient (95% CI) | P value |
| Monoclonal therapy | −0.212 (−0.358 to −0.066) | 0.005 |
| Age at response to questionnaire | −0.203 (−0.350 to −0.057) | 0.007 |
Increasing age and use of monoclonal therapy (infliximab, adalimumab, ustekinumab or vedolizumab) are predictors of reduced school attendance.
Dependent variable: School attendance (%). Independent variables: age at questionnaire, age at diagnosis, sex, thiopurine/methotrexate treatment, diagnosis (CD, UC or IBDU) and time with disease.
IBDU, inflammatory bowel disease unclassified.